Skip to main content
Top
Published in: Journal of Clinical Immunology 5/2013

01-07-2013 | Original Research

Lung Parenchyma Surgery in Autosomal Dominant Hyper-IgE Syndrome

Authors: Alexandra F. Freeman, Ellen D. Renner, Carolyn Henderson, Anne Langenbeck, Kenneth N. Olivier, Amy P. Hsu, Beate Hagl, Annette Boos, Joie Davis, Beatriz E. Marciano, Lisa Boris, Pamela Welch, Julie Sawalle-Belohradsky, Bernd H. Belohradsky, King F. Kwong, Steven M. Holland

Published in: Journal of Clinical Immunology | Issue 5/2013

Login to get access

Abstract

Purpose

Autosomal dominant hyper-IgE syndrome (AD-HIES) due to heterozygous STAT3 mutation is a primary immunodeficiency characterized by eczema, elevated serum IgE, recurrent infections, and connective tissue and skeletal findings. Healing of pneumonias is often abnormal with formation of pneumatoceles and bronchiectasis. We aimed to explore whether healing after lung surgery is also aberrant.

Methods

We retrospectively analyzed the medical records of 32 patients with AD-HIES who received lung surgery for the management of pulmonary infections from 1960 to 2011. We collected information including patient demographics, STAT3 mutation status, clinical history, surgical and medical procedures performed, complications, related medical treatments, and outcomes.

Results

More than 50 % of lung surgeries had associated complications, with the majority being prolonged bronchopleural fistulae. These fistulae often led to empyemas that necessitated additional interventions including prolonged antibiotics, prolonged thoracostomy tube drainage and re-operations.

Conclusion

Lung surgery in AD-HIES patients is associated with high complication rates. STAT3 mutations likely lead to abnormalities in tissue remodelling that are further exacerbated by infection.
Literature
1.
go back to reference Holland SM, DeLeo FR, Elloumi HZ, et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med. 2007;357:1608–19.PubMedCrossRef Holland SM, DeLeo FR, Elloumi HZ, et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med. 2007;357:1608–19.PubMedCrossRef
2.
go back to reference Minegishi Y, Saito M, Tsuchiya S, et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature. 2007;448:1058–62.PubMedCrossRef Minegishi Y, Saito M, Tsuchiya S, et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature. 2007;448:1058–62.PubMedCrossRef
3.
go back to reference Sowerwine KJ, Holland SM, Freeman AF. Hyper-IgE syndrome update. Ann N Y Acad Sci. 2012;1250:25–32.PubMedCrossRef Sowerwine KJ, Holland SM, Freeman AF. Hyper-IgE syndrome update. Ann N Y Acad Sci. 2012;1250:25–32.PubMedCrossRef
4.
go back to reference Chandesris M, Melki I, Natividad A, et al. Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey. Medicine. 2012;91:e1–e19.PubMedCrossRef Chandesris M, Melki I, Natividad A, et al. Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey. Medicine. 2012;91:e1–e19.PubMedCrossRef
5.
go back to reference Freeman AF, Kleiner DE, Nadiminti H, et al. Causes of death in hyper-IgE syndrome. J Allergy Clin Immunol. 2007;119:1234–40.PubMedCrossRef Freeman AF, Kleiner DE, Nadiminti H, et al. Causes of death in hyper-IgE syndrome. J Allergy Clin Immunol. 2007;119:1234–40.PubMedCrossRef
6.
go back to reference Melia E, Freeman AF, Shea YR, et al. Pulmonary nontuberculous mycobacterial infections in hyper-IgE syndrome. J Allergy Clin Immunol. 2009;124:617–8.PubMedCrossRef Melia E, Freeman AF, Shea YR, et al. Pulmonary nontuberculous mycobacterial infections in hyper-IgE syndrome. J Allergy Clin Immunol. 2009;124:617–8.PubMedCrossRef
7.
go back to reference Vinh DC, Sugui JA, Hsu AP, et al. Invasive fungal disease in autosomal-dominant hyper-IgE syndrome. J Allergy Clin Immunol. 2010;125:1389–90.PubMedCrossRef Vinh DC, Sugui JA, Hsu AP, et al. Invasive fungal disease in autosomal-dominant hyper-IgE syndrome. J Allergy Clin Immunol. 2010;125:1389–90.PubMedCrossRef
8.
go back to reference Grimbacher B, Schaffer A, Holland SM, et al. Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet. 1999;65:735–44.PubMedCrossRef Grimbacher B, Schaffer A, Holland SM, et al. Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet. 1999;65:735–44.PubMedCrossRef
9.
go back to reference Schimke LF, Sawalle-Belohradsky J, Roesler J, et al. Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis. J Allergy Clin Immunol. 2010;126:611–7.e.1.PubMedCrossRef Schimke LF, Sawalle-Belohradsky J, Roesler J, et al. Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis. J Allergy Clin Immunol. 2010;126:611–7.e.1.PubMedCrossRef
10.
go back to reference Heimall J, Davis J, Shaw PA, et al. Paucity of genotype-phenotype correlations in STAT3 mutation positive Hyper IgE syndrome (HIES). Clin Immunol. 2011;139:75–84.PubMedCrossRef Heimall J, Davis J, Shaw PA, et al. Paucity of genotype-phenotype correlations in STAT3 mutation positive Hyper IgE syndrome (HIES). Clin Immunol. 2011;139:75–84.PubMedCrossRef
11.
go back to reference Sagan D, Gozdziuk K, Korobowicz E. Predictive and prognostic value of preoperative symptoms in the surgical treatment of pulmonary aspergilloma. J Surg Res. 2010;163:e35–43.PubMedCrossRef Sagan D, Gozdziuk K, Korobowicz E. Predictive and prognostic value of preoperative symptoms in the surgical treatment of pulmonary aspergilloma. J Surg Res. 2010;163:e35–43.PubMedCrossRef
12.
go back to reference Sagan D, Gozdziuk K. Surgery for pulmonary aspergilloma in immunocompetent patients: no benefit from adjuvant antifungal pharmacotherapy. Ann Thorac Surg. 2010;89:1603–10.PubMedCrossRef Sagan D, Gozdziuk K. Surgery for pulmonary aspergilloma in immunocompetent patients: no benefit from adjuvant antifungal pharmacotherapy. Ann Thorac Surg. 2010;89:1603–10.PubMedCrossRef
13.
go back to reference Sekhsaria V, Dodd LE, Hsu AP. Plasma metalloproteinase levels are dysregulated in signal transduction and transcription 3 mutated hyper-IgE syndrome. J Allergy Clin Immunol. 2011;128:1124–7.PubMedCrossRef Sekhsaria V, Dodd LE, Hsu AP. Plasma metalloproteinase levels are dysregulated in signal transduction and transcription 3 mutated hyper-IgE syndrome. J Allergy Clin Immunol. 2011;128:1124–7.PubMedCrossRef
14.
go back to reference Crosby LM, Waters CM. Epithelial repair mechanisms in the lung. Am J Physiol Lung Cell Mol Physiol. 2010;298:L715–31.PubMedCrossRef Crosby LM, Waters CM. Epithelial repair mechanisms in the lung. Am J Physiol Lung Cell Mol Physiol. 2010;298:L715–31.PubMedCrossRef
15.
go back to reference Lagente V, Boichot E. Role of matrix metalloproteinases in the inflammatory process of respiratory diseases. J Mol Cell Cardiol. 2010;48:440–4.PubMedCrossRef Lagente V, Boichot E. Role of matrix metalloproteinases in the inflammatory process of respiratory diseases. J Mol Cell Cardiol. 2010;48:440–4.PubMedCrossRef
16.
go back to reference Kida H, Mucenski ML, Thitoff AR, et al. GP130-STAT3 regulates epithelial cell migration and is required for repair of the bronchiolar epithelium. Am J Pathol. 2008;172:1542–54.PubMedCrossRef Kida H, Mucenski ML, Thitoff AR, et al. GP130-STAT3 regulates epithelial cell migration and is required for repair of the bronchiolar epithelium. Am J Pathol. 2008;172:1542–54.PubMedCrossRef
17.
go back to reference Goussetis E, Peristeri I, Kitra V, et al. Successful long-term immunologic reconstitution by allogeneic hematopoietic stem cell transplantation cures patients with autosomal dominant hyper-IgE syndrome. J Allergy Clin Immunol. 2010;126:392–4.PubMedCrossRef Goussetis E, Peristeri I, Kitra V, et al. Successful long-term immunologic reconstitution by allogeneic hematopoietic stem cell transplantation cures patients with autosomal dominant hyper-IgE syndrome. J Allergy Clin Immunol. 2010;126:392–4.PubMedCrossRef
Metadata
Title
Lung Parenchyma Surgery in Autosomal Dominant Hyper-IgE Syndrome
Authors
Alexandra F. Freeman
Ellen D. Renner
Carolyn Henderson
Anne Langenbeck
Kenneth N. Olivier
Amy P. Hsu
Beate Hagl
Annette Boos
Joie Davis
Beatriz E. Marciano
Lisa Boris
Pamela Welch
Julie Sawalle-Belohradsky
Bernd H. Belohradsky
King F. Kwong
Steven M. Holland
Publication date
01-07-2013
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 5/2013
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-013-9890-5

Other articles of this Issue 5/2013

Journal of Clinical Immunology 5/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.